Skip to search formSkip to main contentSkip to account menu

FCC5

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Some Anti‐allergic and Anti‐inflammatory Actions of 2‐N ‐Carboxamidinonormianserin (FCC5)
The aims of these studies were to examine the effects of FCC5 (2‐carboxamidino‐1,2,3,4,10,14b‐hexahydrodibenzo (c,f) pyrazino (1… 
1992
1992
Pharmacological Evaluation of the Histamine H1 and 5‐HT Blocking Properties of 2‐N‐(Carboxamidinonormianserin) (FCC5): in‐vitro studies
Abstract— Some in‐vitro pharmacological effects of a novel analogue of mianserin, 2‐carboxamidino‐1,2,3,4,10,14b‐hexahydrodibenzo… 
1992
1992
PHARMACOLOGICAL EVALUATION OF TWO NOVEL ANALOGUES OF MIANSERIN: 2‐N‐CARBOXAMIDINONORMIANSERIN(FCC5) AND 2‐N‐CARBOXAMIDONORMIANSERIN (FCC13)
1. The pharmacological properties have been examined of FCC5 (2‐N‐carboxamidinonormianserin) and FCC 13 (2‐N… 
1992
1992
In‐Vivo Pharmacological Studies of 2‐N‐Carboxamidinonormianserin, a Histamine and 5‐Hydroxytryptamine Antagonist Lacking Central Effects
Abstract— The in‐vivo pharmacological properties have been examined of FCC5 (2‐N‐carboxamidino‐1, 2, 3, 4, 10, 14b… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)